Men at risk of prostate cancer take precautions, study shows
Brothers of diagnosed prostate cancer patients are aware of the increased risk of possibly developing prostate cancer and have taken complementary or alternative medicine associated with prostate health as a result, according to a study by the University of Michigan Health System published in Cancer (2004;100:1537-44).
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.